We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

MIT, E8 Sue Navigenics Over Genetic Testing Patent

Law360 (May 20, 2009, 12:00 AM EDT) -- The Massachusetts Institute of Technology and E8 Pharmaceuticals LLC have sued Navigenics Inc., claiming the genetics testing company infringes MIT's patent for genetic analysis.

In a complaint filed Tuesday in the U.S. District Court for the District of Massachusetts, MIT and E8, which licenses the patent from MIT, claim that Navigenics infringes the patent by providing commercial genetic counseling and clinical testing services using products manufactured by another genetic analysis company.

MIT claims that it is the assignee of the patent-at-issue in the suit, U.S. Patent...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.